IN8bio, Inc. (INAB) earnings
INAB earnings moved a median of +0.47% by the close. Quarterly and annual INAB reports and results, each read against the price at its own news timestamp. Back to the INAB overview →
24 measured INAB earnings events.
Where these INAB earnings landedvs 24 measured INAB earnings reactions
| Middle 50% of INAB earnings reactions | -3.19% to +2.66% |
|---|---|
| Median reaction (to close) | +0.47% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 INAB earnings events with a measured close landed between -3.19% and +2.66%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q IN8BIO, INC. For: Sep 30 | SEC filing · Form 10-Q | — | +1.94% | |
| IN8bio Reports Third Quarter 2026 Financial Results and Recent Business Highlights | Press release | — | +1.94% | |
| Form 10-Q IN8BIO, INC. For: Jun 30 | SEC filing · Form 10-Q | — | +1.05% | |
| IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights | Press release | — | +1.05% | |
| Form 10-Q IN8BIO, INC. For: Mar 31 | SEC filing · Form 10-Q | -2.34% | -4.82% | |
| IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights | Press release | -2.34% | -4.82% | |
| Form 10-K IN8BIO, INC. For: Dec 31 | SEC filing · Form 10-K | -9.00% | -5.50% | |
| Form 10-Q IN8BIO, INC. For: Sep 30 | SEC filing · Form 10-Q | +5.31% | -3.13% | |
| IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights | Press release | +5.31% | -3.13% | |
| Form 10-Q IN8BIO, INC. For: Jun 30 | SEC filing · Form 10-Q | +3.72% | +7.44% | |
| IN8bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights | Press release | +3.72% | +7.44% | |
| Form 10-K/A IN8BIO, INC. For: Dec 31 | SEC filing · Form 10-K | -0.59% | -0.06% | |
| Form 10-Q IN8BIO, INC. For: Mar 31 | SEC filing · Form 10-Q | -0.59% | -0.06% | |
| IN8bio Reports First Quarter 2025 Financial Results and Recent Business Highlights | Press release | -0.59% | -0.06% | |
| Form 10-K IN8BIO, INC. For: Dec 31 | SEC filing · Form 10-K | +0.91% | -1.96% | |
| Form 10-Q IN8BIO, INC. For: Sep 30 | SEC filing · Form 10-Q | +6.64% | +5.18% | |
| IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | +6.64% | +5.18% | |
| Form 10-Q IN8BIO, INC. For: Jun 30 | SEC filing · Form 10-Q | -8.00% | -6.81% | |
| IN8bio Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | -8.00% | -6.81% | |
| Form 10-Q IN8BIO, INC. For: Mar 31 | SEC filing · Form 10-Q | — | +1.00% | |
| IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | — | +1.00% | |
| Form 10-K IN8BIO, INC. For: Dec 31 | SEC filing · Form 10-K | +0.85% | -3.39% | |
| Form 10-Q IN8BIO, INC. For: Sep 30 | SEC filing · Form 10-Q | — | +4.84% | |
| IN8bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Press release | — | +4.84% |
Keep exploring
More INAB: analyst actions → · SEC filings → · INAB overview →